[go: up one dir, main page]

HK1180315A - Kinase inhibitors and their use in treating cancer - Google Patents

Kinase inhibitors and their use in treating cancer Download PDF

Info

Publication number
HK1180315A
HK1180315A HK13107552.0A HK13107552A HK1180315A HK 1180315 A HK1180315 A HK 1180315A HK 13107552 A HK13107552 A HK 13107552A HK 1180315 A HK1180315 A HK 1180315A
Authority
HK
Hong Kong
Prior art keywords
treating cancer
kinase inhibitors
kinase
inhibitors
cancer
Prior art date
Application number
HK13107552.0A
Other languages
Chinese (zh)
Other versions
HK1180315B (en
Inventor
Peter Brent Sampson
Yong Liu
Sze-Wan Li
Bryan T. Forrest
Heinz W. Pauls
Louise G. Edwards
Miklos Feher
Narendra Kumar B. Patel
Radoslaw Laufer
Guohua Pan
Original Assignee
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network filed Critical University Health Network
Publication of HK1180315A publication Critical patent/HK1180315A/en
Publication of HK1180315B publication Critical patent/HK1180315B/en

Links

HK13107552.0A 2010-04-06 2011-04-06 Kinase inhibitors and their use in treating cancer HK1180315B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CAPCT/CA2010/000518 2010-04-06
US61/321,329 2010-04-06
US61/321,332 2010-04-06

Publications (2)

Publication Number Publication Date
HK1180315A true HK1180315A (en) 2013-10-18
HK1180315B HK1180315B (en) 2017-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
SI2556071T1 (en) Kinase inhibitors and their use in treating cancer
IL238400A (en) Triazolopyrazines as brd4 inhibitors for use in the treatment of cancer
ZA201300255B (en) Morpholino pyrimidines and their use in therapy
ZA201101586B (en) Aminotriazolopyridines and their use as kinase inhibitors
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
IL214626A0 (en) Prodrug forms of kinase inhibitors and their use in therapy
ZA201108622B (en) Pyrazolopyrimidines and related heterocycles as kinase inhibitors
EP2549963A4 (en) Systems and methods for prostate treatment
SI2483278T1 (en) Benzoxazepin pi3k inhibitor compounds and their use in the treatment of cancer
IL232353B (en) Nedd8-activating enzyme inhibitor and hypomethylating agent for use in treating cancer
SG10201500124VA (en) Methods and Compositions for Treating Cancer
IL228847A0 (en) Il-1r1 inhibitors and their use in cancer therapy
IL218182A0 (en) Kinase inhibitors, prodrug forms thereof and their use in therapy
ZA201204423B (en) Neuregulin antagonists and use thereof in treating cancer
HRP20171280T1 (en) Pyrazolylguanidine F1F0-ATPase Inhibitors and Their Use in Therapy
IL202307A0 (en) Multikinase inhibitors for use in the treatment of cancer
IL233080A0 (en) Bisarylsulfonamides useful in the treatment of inflammation and cancer
EP2537031A4 (en) Compositions and methods for treating cancer
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
HK1180315A (en) Kinase inhibitors and their use in treating cancer
HK1174257A (en) Phytocannabinoids in the treatment of cancer
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
AU2011211693B2 (en) Pharmaceutical composition for treating and/or preventing cancer
ZA201105917B (en) Prodrug forms of kinase inhibitors and their use in therapy
HK1190100A (en) Compositions comprising a pi3k inhibitor and a mek inhibitor and their use for treating cancer